Application 091689
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 1.5MG BASE | No | No |
| 002 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 3MG BASE | No | No |
| 003 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 4.5MG BASE | No | No |
| 004 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 6MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091689-001 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | |
| A091689-002 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | |
| A091689-003 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | |
| A091689-004 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091689-001 | AB |
| A091689-002 | AB |
| A091689-003 | AB |
| A091689-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091689-001 | RIVASTIGMINE TARTRATE | EQ 1.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091689-002 | RIVASTIGMINE TARTRATE | EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091689-003 | RIVASTIGMINE TARTRATE | EQ 4.5MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091689-004 | RIVASTIGMINE TARTRATE | EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-06-12 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091689-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091689-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091689-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091689-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091689-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091689-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091689-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091689-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A091689-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091689-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091689-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091689-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091689-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091689-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091689-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091689-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091689-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091689-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091689-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091689-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091689-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091689-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091689-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091689-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091689-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091689-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091689-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091689-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091689-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091689-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091689-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091689-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091689-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091689-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091689-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091689-004 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A091689-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091689-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091689-003 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091689-004 | AB | 1 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Alembic Pharmaceuticals Limited | 33e6a772-382d-45f5-9d45-966c07759367 | 2023-01-16 | Warnings, Adverse reactions | 091689 ANDA091689 46708-065 46708-066 46708-063 46708-064 |
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Alembic Pharmaceuticals Inc. | 0044f1d7-613c-4611-8481-13032c8cb390 | 2022-03-21 | Warnings, Adverse reactions | 091689 ANDA091689 62332-066 62332-064 62332-065 62332-063 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 46708-063 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-063 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-064 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-064 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-065 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-065 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-066 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-066 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Limited | ANDA | Current |
| 51991-793 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-793 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-793 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-793 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-794 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-794 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-794 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-794 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-795 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-795 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-795 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-795 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-796 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-796 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-796 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 51991-796 | Rivastigmine Tartrate | Rivastigmine Tartrate | Breckenridge Pharmaceutical, Inc | ANDA | Current |
| 60687-574 | Rivastigmine Tartrate | Rivastigmine Tartrate | American Health Packaging | ANDA | Current |
| 60687-574 | Rivastigmine Tartrate | Rivastigmine Tartrate | American Health Packaging | ANDA | Current |
| 60687-574 | Rivastigmine Tartrate | Rivastigmine Tartrate | American Health Packaging | ANDA | Current |
| 62332-063 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-064 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-065 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-066 | Rivastigmine Tartrate | Rivastigmine Tartrate | Alembic Pharmaceuticals Inc. | ANDA | Current |